Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: Data from the Swedish Dementia Quality Registry (SveDem)

Neuropsychiatric Disease and Treatment

Volumn 9, Issue , 2013, Pages 927-935

  Fereshtehnejad, Seyed Mohammad ^a   Religa, Dorota ^a,b   Westman, Eric ^a   Aarsland, Dag ^a,c   Lökk, Johan ^a,b   Eriksdotter, Maria ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Age; Dementia with Lewy bodies; Diagnostic approach; Medication; Mini Mental State Examination; Parkinson's disease with dementia

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CARDIOVASCULAR AGENT; CHOLINESTERASE INHIBITOR; HYPNOTIC AGENT; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT;

AGED; ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIAGNOSTIC TEST; DIFFUSE LEWY BODY DISEASE; DISEASE REGISTRY; FEMALE; FOLLOW UP; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREVALENCE; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SWEDEN;

EID: 84879822790     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S45840     Document Type: Article

References (38)

1. Perez F, Helmer C, Dartigues JF, Auriacombe S, Tison F. A 15-year population-based cohort study of the incidence of Parkinson's disease and dementia with Lewy bodies in an elderly French cohort. J Neurol Neurosurg Psychiatry. 2010;81(7):742-746.
2. Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sørensen P. Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology. 2001;56(6):730-736.
3. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol. 2003;60(3):387-392.
4. Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord. 2005;20(10): 1255-1263.
5. McKeith I, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of the Lewy body type. BMJ. 1992;305(6855):673-678.
6. Svenningsson P, Westman E, Ballard C, Aarsland D. Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol. 2012;11(8):697-707.
7. McKeith IG, Dickson DW, Lowe J, et al; for Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12):1863-1872.
8. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord. 2007;22(12):1689-1707; quiz 1837.
9. Swedish Dementia Registry [homepage on the Internet]. Available from: http://www.svedem.se. Accessed on June 6, 2013.
10. Religa D, Spångberg K, Wimo A, Edlund AK, Winblad B, Eriksdotter-Jönhagen M. Dementia diagnosis differs in men and women and depends on age and dementia severity: data from SveDem, the Swedish Dementia Quality Registry. Dement Geriatr Cogn Disord. 2012;33(2-3):90-95.
11. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research. Geneva, Switzerland: World Health Organization; 1993.
12. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
13. Sharma H, Desai N, Ganjiwale J. Comparison of MMSE to DSM-IV diagnostic criteria for the detection of delirium in medically ill patients with psychiatric referrals. Journal of Mental Health and Human Behaviour. 2011;16(1):37-42.
14. Richard IH, Papka M, Rubio A, Kurlan R. Parkinson's disease and dementia with Lewy bodies: one disease or two? Mov Disord. 2002; 17(6):1161-1165.
15. Horimoto Y, Matsumoto M, Nakazawa H, etal. Cognitive conditions of pathologically confirmed dementia with Lewy bodies and Parkinson's disease with dementia. J Neurol Sci. 2003;216(1):105-108.
16. Goldmann Gross R, Siderowf A, Hurtig HI. Cognitive impairment in Parkinson's disease and dementia with lewy bodies: a spectrum of disease. Neurosignals. 2008;16(1):24-34.
17. McKeith I. Dementia with Lewy bodies and Parkinson's disease with dementia: where two worlds collide. Pract Neurol. 2007;7(6): 374-382.
18. McKeith I, Mintzer J, Aarsland D, et al; for International Psychogeriatric Association Expert Meeting on DLB. Dementia with Lewy bodies. Lancet Neurol. 2004;3(1):19-28.
19. Revuelta GJ, Lippa CF. Dementia with Lewy bodies and Parkinson's disease dementia may best be viewed as two distinct entities. Int Psychogeriatr. 2009;21(2):213-216.
20. Buter TC, van den Hout A, Matthews FE, Larsen JP, Brayne C, Aarsland D. Dementia and survival in Parkinson disease: a 12-year population study. Neurology. 2008;70(13):1017-1022.
21. Socialstyrelsen. Nationella riktlinjer för vård och omsorg vid demenssjukdom [homepage on the Internet]. Stockholm, Sweden: Socialstyrelsen; 2013. Available from: http://www.socialstyrelsen.se/ nationellariktlinjerforvardochomsorgviddemenssjukdom. Accessed September 2, 2012. Swedish.
22. Vaamonde-Gamo J, Flores-Barragán JM, Ibáñez R, Gudín M, Hernández A. DaT-SCAN SPECT in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease. Rev Neurol. 2005;41(5):276-279. Spanish.
23. Sorbi S, Hort J, Erkinjuntti T, et al; for EFNS Scientist Panel on Dementia and Cognitive Neurology. EFNS-ENS guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol. 2012;19(9):1159-1179.
24. Noe E, Marder K, Bell KL, Jacobs DM, Manly JJ, Stern Y. Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia. Mov Disord. 2004;19(1):60-67.
25. Ballard CG, Aarsland D, McKeith I, et al. Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology. 2002;59(11): 1714-1720.
26. Cormack F, Aarsland D, Ballard C, Tovée MJ. Pentagon drawing and neuropsychological performance in dementia with Lewy bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia. Int J Geriatr Psychiatry. 2004;19(4):371-377.
27. Aarsland D, Ballard C, Larsen JP, McKeith I. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. Int J Geriatr Psychiatry. 2001;16(5): 528-536.
28. Downes JJ, Priestley NM, Doran M, Ferran J, Ghadiali E, Cooper P. Intellectual, mnemonic, and frontal functions in dementia with Lewy bodies: a comparison with early and advanced Parkinson's disease. Behav Neurol. 1998;11(3):173-183.
29. Gnanalingham KK, Byrne EJ, Thornton A, Sambrook MA, Bannister P. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiatry. 1997;62(3):243-252.
30. Johnell C, Religa D, Eriksdotter M. Dementia disorders and drug therapy: a nationwide study of over 7000 patients-data from SveDem. Ger Dem Cogn Disord. 2013;35(5-6):239-248.
31. van Laar T, De Deyn PP, Aarsland D, Barone P, Galvin JE. Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data. CNS Neurosci Ther. 2011;17(5):428-441.
32. Hindle JV. The practical management of cognitive impairment and psychosis in the older Parkinson's disease patient. J Neural Transm. 2013;120(4):649-653.
33. Weintraub D, Somogyi M, Meng X. Rivastigmine in Alzheimer's disease and Parkinson's disease dementia: an ADAS-cog factor analysis. Am J Alzheimers Dis Other Demen. 2011;26(6):443-449.
34. Rolinski M, Fox C, Maidment I, McShane R. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. Cochrane Database Syst Rev. 2012;3:CD006504.
35. SveDem: Svenska Demensregistret. SveDem annual report 2011 (in Swedish) [homepage on the Internet]. Available from: http://www.ucr.uu.se/svedem/. Accessed May 19, 2013.
36. Merims D, Giladi N. Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease. Parkinsonism Relat Disord. 2008;14(4):273-280.
37. Ballard C, Kahn Z, Corbett A. Treatment of dementia with Lewy bodies and Parkinson's disease dementia. Drugs Aging. 2011;28(10): 769-777.
38. Sköldunger A, Wimo A, Johnell K. Net costs of dementia in Sweden an incidence based 10 year simulation study. Int J Geriatr Psychiatry. 2012;27(11):1112-1117.